Stay updated on Global Cohort Study: Remibrutinib Clinical Trial

Sign up to get notified when there's something new on the Global Cohort Study: Remibrutinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Global Cohort Study: Remibrutinib Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page footer’s ClinicalTrials.gov software revision changed from v3.8.0 to v3.8.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-18T02:47:12.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page displays the ClinicalTrials.gov record for Novartis’s remibrutinib managed-access program for adults with chronic spontaneous urticaria, including eligibility criteria, contact information, treatment details, and record dates.
    Difference
    32%
    Check dated 2026-11-11T01:53:54.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:14:10.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A site-wide NIH notice about terminology during a website transition appears above the 403 error page, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:15:24.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:25:22.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating restricted access to the page.
    Difference
    15%
    Check dated 2026-09-23T00:25:46.000Z thumbnail image

Stay in the know with updates to Global Cohort Study: Remibrutinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Global Cohort Study: Remibrutinib Clinical Trial page.